Format
Sort by
Items per page

Send to

Choose Destination

Selected items

Items: 1 to 20 of 122

1.

Health related quality of life in ureteral stone patients: post-ureterolithiasis.

Rabah DM, Alomar M, Binsaleh S, Arafa MA.

Urol Res. 2011 Oct;39(5):385-8. doi: 10.1007/s00240-011-0375-9. Epub 2011 Apr 3.

PMID:
21461963
2.

Computed tomography angiogram: accuracy in renal surgery.

Rabah DM, Al-Hathal N, Al-Fuhaid T, Raza S, Al-Yami F, Al-Taweel W, Alomar M, Al-Nagshabandi N.

Int J Urol. 2009 Jan;16(1):58-60. doi: 10.1111/j.1442-2042.2008.02171.x.

3.

The utility of unenhanced helical CT in assessing the frequency of ureterolithiasis in Saudi patients.

Al-Nakshabandi NA, Zayed MA, Al-Omar M, Elsharkaway MS, Al-Boukai AA.

Saudi Med J. 2008 Feb;29(2):209-12.

PMID:
18246228
4.
5.
6.

(E)-2-Cyano-N'-(1,2,3,4-tetra-hydro-naphthalen-1-yl-idene)acetohydrazide.

Al-Omar MA, Khalifa NM, Ghabbour HA, Chia TS, Fun HK.

Acta Crystallogr Sect E Struct Rep Online. 2012 Jun 1;68(Pt 6):o1740. doi: 10.1107/S160053681202106X. Epub 2012 May 16.

7.

Ethyl 2-amino-4-(4-fluoro-phen-yl)-6-meth-oxy-4H-benzo[h]chromene-3-carboxyl-ate.

El-Agrody AM, Al-Omar MA, Amr AG, Chia TS, Fun HK.

Acta Crystallogr Sect E Struct Rep Online. 2012 Jun 1;68(Pt 6):o1803-4. doi: 10.1107/S1600536812021939. Epub 2012 May 19.

8.

Methyl 2-{6-[(1-meth-oxy-1-oxopropan-2-yl)amino-carbon-yl]pyridine-2-carboxamido}-propano-ate.

Al-Omar MA, Amr AG, Ghabbour HA, Chia TS, Fun HK.

Acta Crystallogr Sect E Struct Rep Online. 2012 Jun 1;68(Pt 6):o1837-8. doi: 10.1107/S1600536812022258. Epub 2012 May 23.

9.

Methyl 2-({6-[(1-meth-oxy-2-methyl-1-oxopropan-2-yl)carbamo-yl]pyridin-2-yl}formamido)-2-methyl-propano-ate.

Al-Omar MA, Amr AG, Ghabbour HA, Quah CK, Fun HK.

Acta Crystallogr Sect E Struct Rep Online. 2012 May 1;68(Pt 5):o1377-8. doi: 10.1107/S1600536812014651. Epub 2012 Apr 13.

10.

(E)-2-(2,3-Dimethyl-anilino)-N'-(thio-phen-2-yl-methyl-idene)benzohydrazide.

Fun HK, Chia TS, Bhat MA, Al-Omar MA, Abdel-Aziz HA.

Acta Crystallogr Sect E Struct Rep Online. 2012 Aug 1;68(Pt 8):o2524-5. doi: 10.1107/S160053681203259X. Epub 2012 Jul 25.

11.

Synthesis of chiral macrocyclic or linear pyridine carboxamides from pyridine-2,6-dicarbonyl dichloride as antimicrobial agents.

Al-Salahi RA, Al-Omar MA, Amr Ael-G.

Molecules. 2010 Sep 20;15(9):6588-97. doi: 10.3390/molecules15096588.

12.

Synthesis of some new pyridine-2,6-carboxamide-derived Schiff bases as potential antimicrobial agents.

Al-Omar MA, Amr Ael-G.

Molecules. 2010 Jul 6;15(7):4711-21. doi: 10.3390/molecules15074711.

13.

Anti-inflammatory, analgesic, anticonvulsant and antiparkinsonian activities of some pyridine derivatives using 2,6-disubstituted isonicotinic acid hydrazides.

Al-Omar MA, Amr Ael-G, Al-Salahi RA.

Arch Pharm (Weinheim). 2010 Nov;343(11-12):648-56. doi: 10.1002/ardp.201000088.

PMID:
21110344
14.

Anti-inflammatory activities of some newly synthesized pyridinyl- and indazolyl benzamide derivatives.

Hussain AA, Abdulla MM, Amr AE, Al-Omar MA, Shalaby AF.

Bioorg Khim. 2015 Jan-Feb;41(1):102-11.

PMID:
26050478
15.
16.

Synthesis and biological evaluation of some novel cyclic-imides as hypoglycaemic, anti-hyperlipidemic agents.

Abdel-Aziz AA, El-Azab AS, Attia SM, Al-Obaid AM, Al-Omar MA, El-Subbagh HI.

Eur J Med Chem. 2011 Sep;46(9):4324-9. doi: 10.1016/j.ejmech.2011.07.002. Epub 2011 Jul 8.

PMID:
21783284
17.

Design, synthesis and biological evaluation of novel quinazoline derivatives as potential antitumor agents: molecular docking study.

El-Azab AS, Al-Omar MA, Abdel-Aziz AA, Abdel-Aziz NI, el-Sayed MA, Aleisa AM, Sayed-Ahmed MM, Abdel-Hamide SG.

Eur J Med Chem. 2010 Sep;45(9):4188-98. doi: 10.1016/j.ejmech.2010.06.013. Epub 2010 Jun 16.

PMID:
20599299
19.

3-(1-Adamant-yl)-1-{[4-(2-meth-oxy-phen-yl)piperazin-1-yl]meth-yl}-4-methyl-1H-1,2,4-triazole-5(4H)-thione.

Al-Tamimi AM, Bari A, Al-Omar MA, Alrashood KA, El-Emam AA.

Acta Crystallogr Sect E Struct Rep Online. 2010 Jun 23;66(Pt 7):o1756. doi: 10.1107/S1600536810022695.

20.

Chapter 3 famotidine.

Al-Omar MA, Al-Mohizea AM.

Profiles Drug Subst Excip Relat Methodol. 2009;34:115-51. doi: 10.1016/S1871-5125(09)34003-0. Epub 2010 Mar 16. No abstract available.

PMID:
22469173

Supplemental Content

Support Center